Affiliation:
1. North-Western State Medical University named after I.I. Mechnikov, Russia, St. Petersburg;
2. National Medical Research Center named after V.A. Almazova, Russia, St. Petersburg
Abstract
The objective was to improve the surgical treatment tactics in patients with non-small cell lung cancer (NSCLC) and coronary heart disease (CHD), requiring myocardial revascularization.Methods and materials. Two groups consisting of 24 patients operated on for NSCLC were examined. In one group, operations for NSCLC were performed in the second stage after coronary artery bypass grafting (CABG). Survival rates in both groups and factors influencing them were evaluated.Results. The number of postoperative complications in both groups was comparable: 20.8 % in patients with CABG and 16.6 % in the group operated only for NSCLC. Indicators of relapse-free and overall survival did not differ significantly from each other (p=0.90 and p=0.95). Only the stage of the disease (p=0.009) and the implementation of complex cancer treatment in case of its necessity (p=0.035) had a reliably impact on the long-term results of the operation. The first stage of myocardial revascularization surgery did not affect the results of treatment (p=0.94), as well as the age of patients, the volume of performed surgery, the morphological picture of the tumor.Conclusion. The staging approach to the treatment of patients with NSCLC and critical forms of CHD requiring myocardial revascularization is reliable, convenient and does not affect the long-term results of treatment.
Publisher
FSBEI HE I.P. Pavlov SPbSMU MOH Russia
Reference10 articles.
1. Ma X. C., Huang F., Zhang Z. et al. Lung cancer resection with concurrent off-pump coronary artery bypasses: safety and efficiency // J. Thorac. Dis. 2016;8(8):2038–2045.
2. Yeginsu A., Vayvada., Karademir B. C. et al. Combined Off-Pump Coronary Artery Bypass Grafting and Lung Resection in Patients with Lung Cancer Accompanied by Coronary Artery Disease // Braz. J. Cardiovasc. Surg. 2018;33(5):483–489.
3. Porkhanov V. A., Barbukhatti K. O., Kononenko V. B. et al. Simultaneous surgeries with concurrent lung cancer and heart ischemic disease // Grudnaya I Serdechno-Sosudistaya Khirurgiya. 2016;58(2):114–121. (In Russ).
4. Kanzaki R., Kimura T., Kawamura T. et al. Treatment of simultaneously discovered lung cancer and cardiovascular disease: a 20-year singleinstitution experience // Surg Today. 2017;47(6):726–732.
5. Tourmousoglou C. E., Apostolakis E., Dougenis D. Simultaneous occurrence of coronary artery disease and lung cancer: what is the best surgical treatment strategy // Interact. Cardiovasc. Thorac. Surg. 2014;19(4):673–681.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献